Literature DB >> 8923601

The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms.

M M Cerinic1, S Generini, A Pignone, R Casale.   

Abstract

The involvement of the nervous system in SSc is well recognized today. Different pathogenetic mechanisms are suggested that may alternatively explain the multiform appearance of the clinical spectrum (mononeuritis, mononeuritis multiplex, carpal tunnel syndrome, and so forth). It is now clear that the ANS is the earliest structure targeted by the disease in the gastrointestinal tract. The importance of this observation has not yet been adequately interpreted but may, together with the increasing evidence of the nervous system involvement in SSc, become a leading factor in understanding of the importance of the nervous system in the onset, development, and maintenance of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8923601     DOI: 10.1016/s0889-857x(05)70306-9

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  9 in total

1.  Neurosonological and cognitive screening for evaluation of systemic sclerosis patients.

Authors:  B R Sakr; R E Rabea; A M Aboulfotooh; N A Kishk
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

2.  Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma).

Authors:  M Matucci-Cerinic; R Giacomelli; A Pignone; M L Cagnoni; S Generini; R Casale; P Cipriani; A Del Rosso; P Tirassa; Y T Konttinen; B M Kahaleh; P S Fan; M Paoletti; C Marchesi; M Cagnoni; L Aloe
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

3.  Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients.

Authors:  Francesco Masini; Raffaele Galiero; Pia Clara Pafundi; Klodian Gjeloshi; Emanuele Pinotti; Roberta Ferrara; Ciro Romano; Luigi Elio Adinolfi; Ferdinando Carlo Sasso; Giovanna Cuomo
Journal:  J Scleroderma Relat Disord       Date:  2021-06-07

4.  Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire.

Authors:  Brittany L Adler; James W Russell; Laura K Hummers; Zsuzsanna H McMahan
Journal:  J Rheumatol       Date:  2018-06-15       Impact factor: 4.666

Review 5.  The autonomic nervous system in systemic sclerosis. A review.

Authors:  Luca Bertinotti; Stefania Bracci; Francesca Nacci; Nicola Colangelo; Angela Del Rosso; Roberto Casale; Alberto Pignone; Marco Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2003-12-10       Impact factor: 2.980

6.  Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.

Authors:  Pei-Suen Tsou; Pamela J Palisoc; Mustafa Ali; Dinesh Khanna; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2021-07-07       Impact factor: 15.483

Review 7.  Ocular manifestations in patients with systemic sclerosis.

Authors:  Małgorzata Kozikowska; Wojciech Luboń; Eugeniusz J Kucharz; Ewa Mrukwa-Kominek
Journal:  Reumatologia       Date:  2020-12-23

Review 8.  The Interplay between Autonomic Nervous System and Inflammation across Systemic Autoimmune Diseases.

Authors:  Chiara Bellocchi; Angelica Carandina; Beatrice Montinaro; Elena Targetti; Ludovico Furlan; Gabriel Dias Rodrigues; Eleonora Tobaldini; Nicola Montano
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

9.  Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma.

Authors:  Agostino Di Ciaula; Michele Covelli; Massimo Berardino; David Q H Wang; Giovanni Lapadula; Giuseppe Palasciano; Piero Portincasa
Journal:  BMC Gastroenterol       Date:  2008-02-27       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.